DI
AMRX icon

Disciplined Investments’s Amneal Pharmaceuticals AMRX Stock Holding History

Disciplined Investments’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-5
Closed – – 1213
2022
Q2 		$0 Hold
5
– – ﹤0.01% 1242
2022
Q1 		$0 Buy
+5
New +$22 ﹤0.01% 1322

Other funds holding AMRX

FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Disciplined Investments's AMRX Position: Q3 2022 in Review

Disciplined Investments sold out of Amneal Pharmaceuticals (AMRX) in Q3 2022, closing a stake of 5 shares.

Disciplined Investments first reported a position in AMRX in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 154 funds tracked by Wall St. Rank hold AMRX as of Q3 2022.

  • Disciplined Investments reported no remaining Amneal Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Disciplined Investments sold 5 Amneal Pharmaceuticals shares in Q3 2022.
  • Disciplined Investments first reported a position in Amneal Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Disciplined Investments's Amneal Pharmaceuticals position peaked at $0 in Q2 2022.
  • 154 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q3 2022.

Based on Disciplined Investments's 13F filing for Q3 2022, filed 3 Nov 2022.